Role of the vestibular nuclei in endothelin-1-induced barrel rotation in rats

European Journal of Pharmacology

Volumn 454, Issue 2-3, 2002, Pages 199-207

  Kozako, Tomohiro ^a   Kawachi, Akio ^a   Cheng, Shi Bin ^a   Kuchiiwa, Satoshi ^a   Motoya, Toshiro ^a   Nakagawa, Shiro ^a   Yamada, Katsushi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

(Rat); Barrel rotation; c Fos; Endothelin 1; Vestibular nucleus

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); DIZOCILPINE; DIZOCILPINE MALEATE; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PROTEIN C FOS; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY EQUILIBRIUM; BRAIN NERVE CELL; CELL ACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; LATENT PERIOD; LATERAL BRAIN VENTRICLE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; VESTIBULAR NUCLEUS; VESTIBULAR SYSTEM; ANIMAL; DRUG EFFECT; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MOTOR ACTIVITY; ONCOGENE; PHYSIOLOGY; ROTATION; WISTAR RAT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; GENES, FOS; INJECTIONS, INTRAVENTRICULAR; MOTOR ACTIVITY; RATS; RATS, WISTAR; ROTATION; VESTIBULAR NUCLEI;

EID: 0037111506     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02498-6     Document Type: Article

References (50)

1. Bauters C., de Groote P., Adamantidis M., Delcayre C., Hamon M., Lablanche J.M., Bertrand M.E., Dupuis B., Swynghedauw B. Proto-oncogene expression in rabbit aorta after wall injury. First marker of the cellular process leading to restenosis after angioplasty? Eur. Heart J. 13:1992;556-559.
2. Bax W.A., Saxena P.R. The current endothelin receptor classification: time for reconsideration? Trends Pharmacol. Sci. 15:1994;379-386.
3. Becker K., Erdbrügger W., Heinroth-Hoffmann I., Michel M.C., Brodde O.E. Endothelin-induced inositol phosphate formation in rat kidney. Studies on receptor subtypes, G-proteins and regulation during ontogenesis. Naunyn-Schmiedeberg's Arch. Pharmacol. 354:1996;572-578.
4. Cheng S.B., Kuchiiwa S., Nagatomo I., Akasaki Y., Uchida M., Tominaga M., Hashiguchi W., Kuchiiwa T., Nakagawa S. 2,3,7,8-Tetrachlorodibenzo-p-dioxin treatment induces c-Fos expression in the forebrain of the Long-Evans rat. Brain Res. 931:2002;176-180.
5. Chew B.H., Weaver D.F., Balaban C.D., Gross P.M. NMDA mediated metabolic activation of the cerebellar cortex in behaving rats by the neuropeptide endothelin-1. Brain Res. 647:1994;345-352.
6. Cohn M.L., Cohn M. 'Barrel rotation' induced by somatostatin in the non-lesioned rat. Brain Res. 96:1975;138-141.
7. Diamant M., De Wied D. Simultaneous occurrence of barrel rotation and hypothermia in rats following central injection of AVP. Ann. N.Y. Acad. Sci. 689:1993;582-588.
8. Doi K., Tsumoto T., Matsunaga T. Actions of excitatory amino acid antagonists on synaptic inputs to the rat medial vestibular nucleus: an electrophysiological study in vitro. Exp. Brain Res. 82:1990;254-262.
9. Dokas L.A., Zwiers H., Coy D.H., Gispen W.H. Somatostatin and analogs inhibit endogenous synaptic plasma membrane protein phosphorylation in vitro. Eur. J. Pharmacol. 88:1983;185-193.
10. Dragunow M., Faull R. The use of c-Fos as a metabolic maker in neuronal pathway tracing. J. Neurosci. Methods. 29:1989;261-265.
11. Duflo S.G.D., Gestreau C.B.T., Lacour M. Fos expression in the cat brainstem after unilateral vestibular neurectomy. Brain Res. 824:1999;1-17.
12. 2+ transients and contractility in rabbit ventricular myocardium. Life Sci. 62:1998;1485-1489.
13. Fukushima M., Kitahara T., Takeda N., Saika T., Uno A., Kubo T. Role of cholinergic mossy fibers in medial vestibular and prepositus hypoglossal nuclei in vestibular compensation. Neuroscience. 102:2001;159-166.
14. Furuya N., Koizumi T. Neurotransmitters of vestibular commissural inhibition in the cat. Acta Oto-Laryngol. 118:1998;64-71.
15. Gilron I., Quirion R., Coderre T.J. Pre- versus postformalin effects of ketamine or large-dose alfentanil in the rat: discordance between pain behavior and spinal Fos-like immunoreactivity. Anesth. Analg. 89:1999;128-135.
16. Gross P.M., Weaver D.F. A new experimental model of epilepsy based on the intraventricular injection of endothelin. J. Cardiovasc. Pharmacol. 22(Suppl. 8):1993;S282-S287.
17. Gross P.M., Wainman D.S., Espinosa F.J., Nag S., Weaver D.F. Cerebral hypermetabolism produced by intraventricular endothelin-1 in rats: inhibition by nimodipine. Neuropeptides. 21:1992;211-223.
18. Gross P.M., Beninger R.J., Shaver S.W., Wainman D.S., Espinosa F.J., Weaver D.F. Metabolic and neuroanatomical correlates of barrel-rolling and oculoclonic convulsions induced by intraventricular endothelin-1: a novel peptidergic signaling mechanism in visuovestibular and oculomotor regulation? Exp. Brain Res. 95:1993;397-408.
19. Gross P.M., Weaver D.F., Ho L.T., Pang J.J., Edvinsson L. FR139317, a specific ETA-receptor antagonist, inhibits cerebral activation by intraventricular endothelin-1 in conscious rats. Neuropharmacology. 33:1994;1155-1166.
20. Gustave D.D.S., Gestreau C., Tighilet B., Lacour M. Fos expression in the rat brain after exposure to gravito-inertial force changes. Brain Res. 861:2000;333-344.
21. Harvey S.C., Li X., Skolnick P., Kirst H.A. The antibacterial and NMDA receptor activating properties of aminoglycosides are dissociable. Eur. J. Pharmacol. 387:2000;1-7.
22. Herrera D.G., Robertson H.A. Activation of c-Fos in the brain. Prog. Neurobiol. 50:1996;83-107.
23. Hol E.M., Hermens W.T., Verhaagen J., Gispen W.H., Bär P.R. Alpha MSH but not Org 2766 induces expression of c-Fos in cultured rat spinal cord cells. NeuroReport. 4:1993;651-654.
24. 125I]endothelin-1 binding sites: autoradiographic studies in the brain and periphery of various species including humans. J. Cardiovasc. Pharmacol. 13:1989;S162-S165.
25. Hunt S.P., Pini A., Evan G. Induction of c-Fos-like protein in spinal cord neurons following sensory stimulation. Nature. 328:1987;632-634.
26. Katz R.J. Behavioral effects of dynorphin - a novel opioid neuropeptide. Neuropharmacology. 19:1980;801-803.
27. Kaufman G.D., Anderson J.H., Beitz A.J. Brainstem Fos expression following acute unilateral labyrinthectomy in the rat. NeuroReport. 3:1992;829-832.
28. 1 receptor antagonist, losartan, induces barrel rotation in the rat. Eur. J. Pharmacol. 363:1998;103-106.
29. Kinney G.A., Peterson B.W., Slater N.T. The synaptic activation of NMDA receptors in the rat medial vestibular nucleus. J. Neurophysiol. 72:1994;1588-1595.
30. Kitahara T., Fukushima M., Takeda N., Saika T., Kubo T. Effects of pre-flocculectomy on Fos expression and NMDA receptor-mediated neural circuits in the central vestibular system after unilateral labyrinthectomy. Acta Oto-Laryngol. 120:2000;866-871.
31. Kruse H., Van Wimersma Greidanus T.B., De Wied D. Barrel rotation induced by vasopressin and related peptides in rats. Pharmacol. Biochem. Behav. 7:1977;311-313.
32. Kurumaji A., Nehls D.G., Park C.K., McCulloch J. Effects of NMDA antagonists, MK-801 and CPP, upon local cerebral glucose use. Brain Res. 496:1989;268-284.
33. Maione S., D'Amico M., Berrino L., Filippelli A., Leyva J., Rossi F. Involvement of periaqueductal gray area NMDA receptors in endothelin-induced behavioural effects. Eur. J. Pharmacol. 250:1993;209-212.
34. Morgan J.I., Curran T. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes Fos and Jun. Annu. Rev. Neurosci. 14:1991;421-451.
35. Palkovits M. Stress-induced expression of co-localized neuropeptides in hypothalamic and amygdaloid neurons. Eur. J. Pharmacol. 405:2000;161-166.
36. Pan J.B., O'Neill A.B., Hancock A.A., Sullivan J.P., Brioni J.D. Histaminergic ligands attenuate barrel rotation in rats following unilateral labyrinthectomy. Methods Find. Exp. Clin. Pharmacol. 20:1998;771-777.
37. Pellegrino L.J., Pellegrino A.S., Cushmann A.J. A stereoataxic atlas of the rat brain. Second Ed. 1979;Plenum Press, New York.
38. Peterson B.W. Effect of tilting on the activity of neurons in the vestibular nuclei of the cat. Brain Res. 6:1967;606-609.
39. Reichenberger I., Dieringer N. Size-related colocalization of glycine and glutamate immunoreactivity in frog and rat vestibular afferents. J. Comp. Neurol. 349:1994;603-614.
40. Rubertone J.A., Mehler W.R., Voogd J. The Vestibular Nuclear Complex, The Rat Neurons System. 2nd ed. 1995;773-796 Academic Press, California.
41. Saika T., Kiyama H., Senba E., Tohyama M. Expression of c-Fos-like protein following unilateral labyrinthectomy. Neurosci. Res. 16:1991;S36.
42. Schor R.H., Miller A.D. Vestibular reflexes in neck and forelimb muscles evoked by roll and tilt. J. Neurophysiol. 46:1981;167-178.
43. Séquier J.M., Lazdunski M. Mast cell degranulating peptide induces the expression of the c-Fos proto-oncogene in hippocampus. Eur. J. Pharmacol. 180:1990;179-181.
44. Shukla V.K., Prasad J.A., Lemaire S. Nonopioid motor effects of dynorphin A and related peptides: structure dependence and role of the N-methyl-D-aspartate receptor. J. Pharmacol. Exp. Ther. 283:1997;604-610.
45. Takeshita S., Sasa M., Ishihara K., Matsubayashi H., Yajin K., Okada M., Izumi R., Arita K., Kurisu K. Cholinergic and glutamatergic transmission in medial vestibular nucleus neurons responding to lateral roll tilt in rats. Brain Res. 840:1999;99-105.
46. Waele C.D., Vibert N., Baudrimont M., Vidal P.P. NMDA receptors contribute to the resting discharge of vestibular neurons in the normal and hemilabyrinthectomized guinea pig. Exp. Brain Res. 81:1990;125-133.
47. Walberg F., Bowsher D., Brodal A. The termination of primary vestibular fibers in the vestibular nuclei of the cat. J. Comp. Neurol. 110:1958;391-419.
48. Wenzel A., Fritschy J.M., Mohler H., Benke D. NMDA receptor heterogeneity during postnatal development of the rat brain: differential expression of the NR2A, NR2B, and NR2C subunit proteins. J. Neurochem. 68:1997;469-478.
49. Yamada K., Furukawa T. Barrel rotation induced by vasopressin and involvement of dopaminergic and cholinergic functions in rats. Arch. Int. Pharmacodyn. Ther. 251:1981;88-94.
50. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.